BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/21/2021 12:39:35 AM | Browse: 328 | Download: 753
Publication Name World Journal of Hepatology
Manuscript ID 65457
Country/Territory United Arab Emirates
Received
2021-03-07 19:13
Peer-Review Started
2021-03-07 19:19
To Make the First Decision
Return for Revision
2021-03-29 14:51
Revised
2021-03-30 11:20
Second Decision
2021-04-29 09:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-29 11:35
Articles in Press
2021-04-29 11:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-05-06 20:06
Typeset the Manuscript
2021-05-19 01:18
Publish the Manuscript Online
2021-05-20 15:14
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Opinion Review
Article Title COVID-19 and the liver: What do we know so far?
Manuscript Source Invited Manuscript
All Author List Prashant Nasa and George Alexander
Funding Agency and Grant Number
Corresponding Author Prashant Nasa, MD, Chief Doctor, Critical Care Medicine, NMC Specialty Hospital, Amman Street, Al Nahda 2, Dubai 7832, United Arab Emirates. dr.prashantnasa@hotmail.com
Key Words COVID-19; Chronic liver disease; SARS-CoV-2; Severe acute respiratory syndrome coronavirus; Liver transplant; Liver and SARS-CoV-2 vaccines; SARS-CoV-2 induced liver injury
Core Tip Liver involvement in coronavirus disease 2019 (COVID-19) is either due to viral cytotoxicity or secondarily to systemic immune dysregulation. Patients with pre-existing liver disease are at higher risk of disease progression, morbidity, and mortality. Chronic liver disease with COVID-19 should be managed as per the standard guidelines, with education on hand hygiene, social distance, and face masks to reduce hospital admissions. There is no evidence that currently available vaccines for severe acute respiratory syndrome will have any complications different from other inactivated vaccines and are recommended for patients with pre-existing liver disease, hepatocellular carcinoma, or liver transplant recipients.
Publish Date 2021-05-20 15:14
Citation Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532
URL https://www.wjgnet.com/1948-5182/full/v13/i5/522.htm
DOI https://dx.doi.org/10.4254/wjh.v13.i5.522
Full Article (PDF) WJH-13-522.pdf
Full Article (Word) WJH-13-522.docx
Manuscript File 65457-Review-FilipodiaCL.docx
Answering Reviewers 65457-Answering reviewers.pdf
Audio Core Tip 65457-Audio core tip.mp4
Conflict-of-Interest Disclosure Form 65457-Conflict-of-interest statement.pdf
Copyright License Agreement 65457-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 65457-Language certificate.pdf
Peer-review Report 65457-Peer-review(s).pdf
Scientific Misconduct Check 65457-Bing Liu M-1.png
Scientific Misconduct Check 65457-CrossCheck.png
Scientific Misconduct Check 65457-Bing-Gong ZM-2.png
Scientific Misconduct Check 65457-Scientific misconduct check.pdf
Scientific Editor Work List 65457-Scientific editor work list.pdf